查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1728331

辛伐他汀市場－全球產業規模、佔有率、趨勢、機會和預測，按銷售管道、最終用途、地區和競爭細分，2020-2030 年

Simvastatin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel, By End Use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球辛伐他汀市場價值為 1.4693 億美元，預計到 2030 年將達到 2.2687 億美元，預測期內複合年成長率為 6.51%。辛伐他汀是他汀類降膽固醇藥物，廣泛用於治療高膽固醇血症和預防心血管併發症。公眾對預防性醫療保健和膽固醇控制的日益關注，推動了成熟市場和新興市場對其的需求。肥胖、糖尿病和高血壓等生活方式相關疾病的盛行率不斷上升，這為市場帶來了益處，這些疾病會增加心血管風險，促使人們儘早接受他汀類藥物治療。在現有的治療方法中，辛伐他汀仍然是一種成熟且具有成本效益的選擇。低收入國家醫療服務的普及和學名藥價格的提高正在支持市場擴張。然而，該行業也面臨來自替代降血脂療法的競爭、長期使用他汀類藥物的安全性問題以及可能影響製造商定價和利潤率的監管限制。

市場概覽
預測期 2026-2030
2024年市場規模 1.4693億美元
2030年市場規模 2.2687億美元
2025-2030 年複合年成長率 6.51%
成長最快的領域 直接的
最大的市場 亞太地區

關鍵市場促進因素

製藥業的成長

主要市場挑戰

安全性問題和副作用

主要市場趨勢

增加政府醫療支出

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球辛伐他汀市場的影響

第5章：全球辛伐他汀市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按銷售管道（直接、間接）
    • 依最終用途（高血脂、冠心病、糖尿病相關血脂異常、中風、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美辛伐他汀市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲辛伐他汀市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區辛伐他汀市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美辛伐他汀市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲辛伐他汀市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第 13 章：全球辛伐他汀市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • ASolution Pharmaceuticals Pvt. Ltd
  • Cipla Ltd
  • Cadila Healthcare Limited
  • Jsons Laboratories
  • SHIVA LIFE SCIENCE PVT LTD
  • Kaizen Pharmachem
  • Rajem Pharmascience Pvt Ltd
  • Jubilant Generics Limited
  • Chemneal Pharmaceuticals LLP
  • Sun Pharmaceutical Industries Limited

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 29085

The Global Simvastatin Market was valued at USD 146.93 million in 2024 and is projected to reach USD 226.87 million by 2030, growing at a CAGR of 6.51% during the forecast period. Simvastatin, a cholesterol-lowering drug in the statin class, is extensively used for managing hypercholesterolemia and preventing cardiovascular complications. Increasing public focus on preventive healthcare and cholesterol control is fueling its demand across both mature and emerging markets. The market benefits from the rising prevalence of lifestyle-related disorders such as obesity, diabetes, and hypertension-conditions that heighten cardiovascular risks and prompt early statin therapy. Simvastatin remains a well-established and cost-effective option among available treatments. Broader access to healthcare services and greater affordability of generic drugs in lower-income nations are supporting market expansion. However, the industry also contends with competition from alternative lipid-lowering therapies, safety-related concerns regarding long-term statin use, and regulatory constraints that may impact pricing and profit margins for manufacturers.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 146.93 Million
Market Size 2030USD 226.87 Million
CAGR 2025-20306.51%
Fastest Growing SegmentDirect
Largest MarketAsia Pacific

Key Market Drivers

Growth in Pharmaceutical Industry

The expansion of the global pharmaceutical industry is a major driver propelling simvastatin demand. With the pharmaceutical sector generating over USD 1.6 trillion in revenue by 2023, its scale is now comparable to the GDP of entire nations. This growth reflects a heightened industry focus on chronic disease management, including cardiovascular conditions-a key area where statins like simvastatin play a central role. As companies increase investments in accessible, cost-effective therapies, the use of generic statins continues to rise globally. Simvastatin, due to its proven efficacy and affordability, remains a staple treatment, particularly in managing long-term cardiovascular risk in both primary and secondary prevention cases.

Key Market Challenges

Safety Concerns and Side Effects

Safety concerns related to simvastatin pose a significant challenge to its continued uptake. Although effective in managing cholesterol levels and lowering cardiovascular risk, simvastatin has been associated with muscle-related side effects, ranging from mild discomfort to serious conditions such as myopathy and rhabdomyolysis. These risks, especially with prolonged use or when combined with interacting drugs like antifungals or immunosuppressants, have led to increased caution among healthcare providers and patients. Regulatory bodies continue to evaluate the risk-benefit profile of simvastatin, and some patients may avoid or discontinue therapy due to perceived or actual adverse effects. These safety issues can impact treatment adherence and overall market performance.

Key Market Trends

Increasing Government Healthcare Spending

Rising government expenditure on healthcare is a key trend supporting simvastatin market growth. In 2023, the U.S. reported healthcare spending of USD 13,432 per capita-well above the average of USD 7,393 among other high-income countries. Similar trends are emerging globally as nations prioritize public health infrastructure and chronic disease prevention. Simvastatin, frequently included on essential medicine lists, benefits from government-led programs that subsidize or reimburse treatments for hyperlipidemia and cardiovascular disease. By supporting early intervention and preventative care through expanded access to medicines, increased public spending plays a crucial role in boosting simvastatin usage, particularly in regions implementing large-scale cardiovascular disease mitigation strategies.

Key Market Players

  • ASolution Pharmaceuticals Pvt. Ltd
  • Cipla Ltd
  • Cadila Healthcare Limited
  • Jsons Laboratories
  • SHIVA LIFE SCIENCE PVT LTD
  • Kaizen Pharmachem
  • Rajem Pharmascience Pvt Ltd
  • Jubilant Generics Limited
  • Chemneal Pharmaceuticals LLP
  • Sun Pharmaceutical Industries Limited

Report Scope:

In this report, the Global Simvastatin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Simvastatin Market, By Sales Channel:

  • Direct
  • Indirect

Simvastatin Market, By End Use:

  • Hyperlipidemia
  • Coronary Heart Disease
  • Diabetes-Related Dyslipidemia
  • Stroke
  • Others

Simvastatin Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Simvastatin Market.

Available Customizations:

Global Simvastatin Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Simvastatin Market

5. Global Simvastatin Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Sales Channel (Direct, Indirect)
    • 5.2.2. By End Use (Hyperlipidemia, Coronary Heart Disease, Diabetes-Related Dyslipidemia, Stroke, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Simvastatin Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Sales Channel
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Simvastatin Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Sales Channel
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Simvastatin Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Sales Channel
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Simvastatin Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Sales Channel
        • 6.3.3.2.2. By End Use

7. Europe Simvastatin Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Sales Channel
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Simvastatin Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Sales Channel
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Simvastatin Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Sales Channel
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Simvastatin Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Sales Channel
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Simvastatin Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Sales Channel
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Simvastatin Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Sales Channel
        • 7.3.5.2.2. By End Use

8. Asia Pacific Simvastatin Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Sales Channel
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Simvastatin Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Sales Channel
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Simvastatin Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Sales Channel
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Simvastatin Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Sales Channel
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Simvastatin Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Sales Channel
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Simvastatin Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Sales Channel
        • 8.3.5.2.2. By End Use

9. South America Simvastatin Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Sales Channel
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Simvastatin Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Sales Channel
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Simvastatin Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Sales Channel
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Simvastatin Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Sales Channel
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Simvastatin Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Sales Channel
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Simvastatin Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Sales Channel
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Simvastatin Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Sales Channel
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Simvastatin Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Sales Channel
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Simvastatin Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. ASolution Pharmaceuticals Pvt. Ltd
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Cipla Ltd
  • 15.3. Cadila Healthcare Limited
  • 15.4. Jsons Laboratories
  • 15.5. SHIVA LIFE SCIENCE PVT LTD
  • 15.6. Kaizen Pharmachem
  • 15.7. Rajem Pharmascience Pvt Ltd
  • 15.8. Jubilant Generics Limited
  • 15.9. Chemneal Pharmaceuticals LLP
  • 15.10. Sun Pharmaceutical Industries Limited

16. Strategic Recommendations

17. About Us & Disclaimer